BSECompany UpdateResults10h ago
Zim Laboratories Ltd
Please find enclosed the disclosure under Regulation 30 of SEBI LODR Regulations regarding Earnings Presentation for Q1 FY 27
Zim Laboratories Ltd has released its Q1 FY27 earnings presentation, showing a 31.2% increase in total operating income to ₹942 Mn and a 40.0% decline in EBITDA to ₹34 Mn. The company's EBITDA margin decreased by 430 bps to 3.7%. R&D spend increased to ₹82 Mn, with ₹34 Mn allocated towards BE studies and regulatory filings. The company has made progress on its EU-GMP CAPA remediation plan, with most of the plan completed and implemented.
BSEResultResults14h ago
Zim Laboratories Ltd
Please find enclosed the Unaudited Financial Results for the Quarter ended 30th June 2026.
Zim Laboratories Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, with revenue from operations at Rs. 9,417.85 lakhs and total income at Rs. 9,517.08 lakhs.
BSEBoard MeetingResults16h ago
Zim Laboratories Ltd
Please find enclosed the Financial Results for the Quarter ended 30th June 2026.
Zim Laboratories Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, with revenue from operations at Rs. 9,417.85 lakhs and total income at Rs. 9,517.08 lakhs.
BSECompany UpdateResults2d ago
Zim Laboratories Ltd
Please find attached disclosure under Regulation 30 read with Scheduled III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Earnings Conference Call for ....
Zim Laboratories Ltd has announced the schedule for its Q1FY27 Earnings Conference Call, to be held on August 7th, 2026, at 12:00 PM IST.
BSEBoard MeetingResults6d ago
Zim Laboratories Ltd
Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Zim Laboratories Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 06/08/2026 to consider and approve Unaudited Financial Results for the quarter ended 30th June, 2026.
BSECompany UpdateResults30 Jul 2026
Zim Laboratories Ltd
Please find enclosed the disclosure newspaper publication regarding intimation to the shareholder regarding transfer of shares to IEPF Authority
Zim Laboratories Ltd has announced the transfer of shares to IEPF Authority, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has published a notice in newspapers regarding the transfer of equity shares to the IEPF Account. The financial results for the quarter ended June 30, 2026, have been made available on the stock exchange website and the company's website.